HRIPT Study to Evaluate the Irritation and Allergenic Potential of Medical-grade Norway Spruce (Picea Abies) Resin Salve (Abilar)
Clinical trial NCT06810856 · COMPLETED
Trial details
- NCT number
- NCT06810856
- Sponsor
- Repolar Pharmaceuticals Oy
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-16
- Primary completion
- 2019-10-25
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.